Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:DNMR

Danimer Scientific (DNMR) Stock Price, News & Analysis

Danimer Scientific logo

About Danimer Scientific Stock (NYSE:DNMR)

Advanced Chart

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.23
52-Week Range
$0.33
$23.82
Volume
N/A
Average Volume
48,724 shs
Market Capitalization
$60.40 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.75
Consensus Rating
Reduce

Company Overview

Receive DNMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Danimer Scientific and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DNMR Stock News Headlines

Firm Retention Summary: Danimer Scientific
OTC:DNMR.Q (Danimer Scientific)
New Biotech Backed by Proven Incubator Now Open to Public
A successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal comes from the same team that helped guide ANOTHER rare disease biotech to a $680M acquisition. Now, they've lined up a new candidate: a drug with orphan status and fast-track designation, entering Phase 2 trials.tc pixel
Danimer Scientific Files for Bankruptcy
Danimer Scientific, Inc. (DNMR.MX)
NYSE to commence delisting proceedings against Danimer Scientific
See More Headlines

DNMR Stock Analysis - Frequently Asked Questions

Danimer Scientific's stock reverse split before market open on Wednesday, November 13th 2024.The 1-40 reverse split was announced on Friday, November 1st 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Danimer Scientific investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), PayPal (PYPL), JPMorgan Chase & Co. (JPM) and

Company Calendar

Today
9/15/2025
Next Earnings (Estimated)
11/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Plastics materials & resins
Sub-Industry
Chemicals
Current Symbol
NYSE:DNMR
CIK
1779020
Fax
N/A
Employees
280
Year Founded
N/A

Price Target and Rating

High Price Target
$5.50
Low Price Target
$4.00
Potential Upside/Downside
+23,650.0%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($33.78)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$155.47 million
Net Margins
-297.10%
Pretax Margin
-297.08%
Return on Equity
-47.85%
Return on Assets
-17.38%

Debt

Debt-to-Equity Ratio
1.80
Current Ratio
3.28
Quick Ratio
2.05

Sales & Book Value

Annual Sales
$37.43 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$108.14 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
3,020,000
Free Float
2,519,000
Market Cap
$60.40 thousand
Optionable
Optionable
Beta
1.49

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NYSE:DNMR) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners